Genetic and host factors for dementia in Down's syndrome

被引:129
作者
Schupf, N
机构
[1] New York State Inst Basic Res Dev Disabil, Lab Epidermiol, Staten Isl, NY 10314 USA
[2] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA
关键词
D O I
10.1192/bjp.180.5.405
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background The high risk for dementia in adults with Down's syndrome has been attributed to triplication and overexpression of the gene for amyloid precursor protein (APP). But the wide variation in age at onset must be due to other risk factors. Aims To identify factors which influence age at onset of dementia in Down's syndrome. Method Studies of factors which influence formation of beta-amyloid (Abeta) were reviewed, including atypical karyotypes, susceptibility genotypes, gender and oestrogen deficiency, and individual differences in Abeta peptide levels. Results The apolipoprotein E epsilon4 allele, oestrogen deficiency and high levels of AbetaI-42 peptide are associated with earlier onset of dementia, while atypical karyotypes and the apolipoprotein E epsilon2 allele are associated with reduced mortality and reduced risk of dementia. Conclusions Factors which influence Abeta levels, rather than overexpression of APP, may account for the differences in age at onset of dementia in Down's syndrome, Declaration of interest Grants IIRG-90-067 and RG3-96-077 from the Alzheimer's Association, Federal grants AG14673, HD35897, P50AG08702 and funds from New York State through its Off ice of Mental Retardation and Developmental Disabilities.
引用
收藏
页码:405 / 410
页数:6
相关论文
共 83 条
[1]   Diagnosis of dementia in individuals with intellectual disability [J].
Aylward, EH ;
Burt, DB ;
Thorpe, LU ;
Lai, F ;
Dalton, A .
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 1997, 41 :152-164
[2]   INCIDENCE OF DEMENTIA AND PROBABLE ALZHEIMERS-DISEASE IN A GENERAL-POPULATION - THE FRAMINGHAM-STUDY [J].
BACHMAN, DL ;
WOLF, PA ;
LINN, RT ;
KNOEFEL, JE ;
COBB, JL ;
BELANGER, AJ ;
WHITE, LR ;
DAGOSTINO, RB .
NEUROLOGY, 1993, 43 (03) :515-519
[3]  
BARRETTCONNER E, 1993, JAMA-J AM MED ASSOC, V569, P2637
[4]  
BENJAMIN R, 1994, LANCET, V344, P473, DOI 10.1016/S0140-6736(94)91804-X
[5]   Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo [J].
Borchelt, DR ;
Thinakaran, G ;
Eckman, CB ;
Lee, MK ;
Davenport, F ;
Ratovitsky, T ;
Prada, CM ;
Kim, G ;
Seekins, S ;
Yager, D ;
Slunt, HH ;
Wang, R ;
Seeger, M ;
Levey, AI ;
Gandy, SE ;
Copeland, NG ;
Jenkins, NA ;
Price, DL ;
Younkin, SG .
NEURON, 1996, 17 (05) :1005-1013
[6]   POSTMENOPAUSAL ESTROGEN REPLACEMENT THERAPY AND THE RISK OF ALZHEIMERS-DISEASE - A POPULATION-BASED CASE-CONTROL STUDY [J].
BRENNER, DE ;
KUKULL, WA ;
STERGACHIS, A ;
VANBELLE, G ;
BOWEN, JD ;
MCCORMICK, WC ;
TERI, T ;
LARSON, EB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (03) :262-267
[7]   SERUM GONADOTROPINS IN DOWNS-SYNDROME [J].
CAMPBELL, WA ;
LOWTHER, J ;
MCKENZIE, I ;
PRICE, WH .
JOURNAL OF MEDICAL GENETICS, 1982, 19 (02) :98-99
[8]  
Chicoine B, 1997, MENT RETARD, V35, P477, DOI 10.1352/0047-6765(1997)035<0477:LOAWWD>2.0.CO
[9]  
2
[10]   PROTECTIVE EFFECT OF APOLIPOPROTEIN-E TYPE-2 ALLELE FOR LATE-ONSET ALZHEIMER-DISEASE [J].
CORDER, EH ;
SAUNDERS, AM ;
RISCH, NJ ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
RIMMLER, JB ;
LOCKE, PA ;
CONNEALLY, PM ;
SCHMADER, KE ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
NATURE GENETICS, 1994, 7 (02) :180-184